Medicure (OTCMKTS:MCUJF) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next?

Shares of Medicure Inc. (OTCMKTS:MCUJF) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.81 and traded as high as $0.9132. Medicure shares last traded at $0.85, with a volume of 10,000 shares trading hands.

Medicure Trading Down 4.2%

The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 1.04. The firm has a fifty day moving average price of $0.76 and a 200 day moving average price of $0.81. The company has a market cap of $8.87 million, a price-to-earnings ratio of -1.81 and a beta of 0.99.

Medicure (OTCMKTS:MCUJF) last posted its quarterly earnings results on Thursday, May 21st. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.01. Medicure had a negative net margin of 21.65% and a negative return on equity of 44.34%. The firm had revenue of $5.79 million for the quarter, compared to analyst estimates of $3.63 million.

About Medicure

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical?care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.